Sen. @PattyMurray from @HELPCmteDems follows up on that Q by noting #340B discounts aren't taxpayer dollars. It's funded 100% by drug company discounts
We can talk about transparency all we want, but let's be clear these aren't wasted taxpayer $ we're talking about, she says
We can talk about transparency all we want, but let's be clear these aren't wasted taxpayer $ we're talking about, she says
https://twitter.com/_jacquie_lee/status/1140992549726957568
.@SenSusanCollins brings up biosimilars & frmr FDA head @ScottGottliebMD's stat that if all biosimilars approved by FDA made it to market consumers save $4.5 billion
Then she brings up bill that would help w patent ticketing (1/2)
Then she brings up bill that would help w patent ticketing (1/2)
The main issue rn for biosimilars isn't that they aren't being approved (so not the patent ticketing issue, although that's a big problem in the drug sphere)
It's that insurers won't cover them. @ihdezdelso does a good job of explaining why here: news.bloomberglaw.com/pharma-and-lif…
It's that insurers won't cover them. @ihdezdelso does a good job of explaining why here: news.bloomberglaw.com/pharma-and-lif…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
